Cite
HARVARD Citation
Panahi, M. et al. (2021). The effect of biosimilar administration on clinical outcomes in patients with adalimumab‐controlled psoriasis. Skin health and disease. 1 (4), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Panahi, M. et al. (2021). The effect of biosimilar administration on clinical outcomes in patients with adalimumab‐controlled psoriasis. Skin health and disease. 1 (4), p. n/a. [Online].